Short-read Sequencing Market Size & Growth Forecast 2027–2036, By Segments (Product, Workflow, Application, End-Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Short-read Sequencing Market size was around USD 8.5 billion in 2026 and is slated to grow at a 17.58% CAGR from 2027 to 2036, surpassing USD 42.93 billion by 2036. The industry revenue for 2027 is calculated at USD 9.76 billion.
Get more details on this report
Request Free Sample ReportShort-read Sequencing Market Intelligence Snapshot
Regional Market Dynamics
- North America held 52.79% of the market in 2026, supported by established genomic research infrastructure, leading sequencing manufacturers, and strong adoption across clinical research, diagnostics, and precision medicine programs.
- Asia Pacific is projected to grow at a 20.5% CAGR as genomics infrastructure expands, laboratory capacity increases, and sequencing adoption accelerates across healthcare, disease research, and large-scale genomics projects.
Segment Momentum
- Consumables represented 60.77% of the market in 2026 because every sequencing run requires recurring purchases of reagents, kits, library preparation materials, and flow cells, creating sustained demand.
- Data Analysis is the fastest-growing workflow segment as rising sequencing volumes increase demand for efficient interpretation of complex datasets and faster generation of actionable research results.
Market Expansion Drivers
- Rising demand for personalized medicine and companion diagnostics accelerating genomic testing adoption.
- Cost-effective high-throughput sequencing enabling large-scale genomic research expansion.
- Expansion of multi-omics and single-cell sequencing workflows enhancing research applications.
Leading Market Participants
- Top players in the short-read sequencing market include Illumina, Inc. (United States), Thermo Fisher Scientific Inc. (United States), BGI Genomics Co., Ltd. (China), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (United States), Revvity, Inc. (United States), Azenta, Inc. (United States), Psomagen, Inc. (United States), F. Hoffmann-La Roche Ltd. (Switzerland).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 8.5 billion
- 2027 Estimated Market Size: USD 9.76 billion.
- Projected Market Size: USD 42.93 billion by 2036
- Growth Forecast: 17.58% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Consumables (Product) | Sequencing (Workflow) | Targeted Sequencing & Resequencing (Application) | Academic & Research Institutes (End-Use)
- Emerging Opportunity Segment: Services (Product) | Data Analysis (Workflow) | Whole Genome Sequencing (Application) | Pharmaceutical & Biotechnology Companies (End-Use)
Market Growth Drivers and Industry Trends
Rising demand for personalized medicine and companion diagnostics accelerating genomic testing adoption
The short-read sequencing market is gaining momentum as personalized medicine and companion diagnostics increase the need for genomic testing across clinical applications. Greater reliance on molecular information for treatment selection and disease characterization is encouraging broader sequencing adoption among healthcare and research workflows.
Cost-effective high-throughput sequencing enabling large-scale genomic research expansion
Cost-effective, high-throughput capabilities are strengthening the short-read sequencing market by making extensive genomic analysis more practical for large-scale research programs. Improved sequencing economics support broader sample processing and enable research organizations to expand genomic studies without proportionally increasing operational requirements.
Expansion of multi-omics and single-cell sequencing workflows enhancing research applications
The expansion of multi-omics and single-cell approaches is broadening applications for the short-read sequencing market across advanced research workflows. These methods allow researchers to examine genomic information alongside other biological characteristics and analyze cellular-level variation, increasing the range of studies that can incorporate sequencing technologies.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Expanding clinical genomics & oncology research adoption | 7.00% | Short term (≤ 2 yrs) | North America, Europe (spillover: Asia Pacific) | High | Fast |
| Growth in personalized medicine & precision diagnostics | 6.20% | Medium term (2–5 yrs) | Asia Pacific, North America (spillover: Europe) | High | Moderate |
| Advances in NGS throughput & cost reduction | 5.10% | Long term (5+ yrs) | Europe, Asia Pacific (spillover: North America) | Medium | Slow |
| Rising demand for personalized medicine and companion diagnostics accelerating genomic testing adoption | 2.40% | High | North America, Europe, Asia Pacific | High | Near Term |
| Cost-effective high-throughput sequencing enabling large-scale genomic research expansion | 1.90% | Moderate | North America, Europe | High | Mid Term |
| Expansion of multi-omics and single-cell sequencing workflows enhancing research applications | 1.60% | Moderate | North America, Asia Pacific | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America dominated the short-read sequencing market with a 52.79% share in 2026, supported by advanced genomics infrastructure, strong research capabilities, and broad adoption of sequencing technologies across clinical research, pharmaceutical development, and molecular diagnostics. The region benefits from established genomic testing workflows and growing demand for high-throughput, accurate sequencing in applications such as disease research, biomarker discovery, and precision medicine. Continued investment in genomic research, expanding use of sequencing in clinical decision-making, and improvements in bioinformatics and laboratory automation are strengthening the integration of short-read platforms across research and healthcare settings.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is emerging as the fastest-growing regional market as healthcare systems expand their genomic capabilities and research institutions increasingly adopt advanced molecular technologies. Growing investments in biotechnology infrastructure, increasing interest in precision medicine, and expanding applications of genomics in disease surveillance and pharmaceutical research are creating favorable conditions for short-read sequencing adoption. Improvements in laboratory capacity and greater awareness of the clinical and research value of genomic analysis are also helping broaden utilization beyond established research centers.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Translational Genomics FocusGermany emphasizes short-read sequencing for clinical research, molecular diagnostics, and academic collaborations. Research institutions increasingly strengthen sequencing capabilities to support biomarker discovery and standardized genomic analysis workflows.
France 🇫🇷
Clinical Genomics DevelopmentFrance continues integrating short-read sequencing into healthcare research and clinical genomics programs. Research organizations increasingly focus on scalable sequencing platforms that support molecular diagnostics, population studies, and translational research initiatives.
Italy 🇮🇹
Academic Sequencing CapacityItaly is expanding the use of short-read sequencing through research institutions, hospitals, and collaborative genomics projects. Italian laboratories increasingly prioritize efficient sequencing workflows that support clinical research and advanced molecular analysis.
Japan 🇯🇵
Precision Diagnostics IntegrationJapan continues expanding short-read sequencing applications across healthcare and life sciences research. Japanese laboratories prioritize reliable sequencing technologies that deliver consistent performance for clinical genomics and disease-focused research programs.
South Korea 🇰🇷
Biotechnology Research SupportSouth Korea is strengthening short-read sequencing capabilities through growing biotechnology investment and genomic research initiatives. Laboratories increasingly adopt automated sequencing workflows that improve throughput and support precision medicine applications.
United States 🇺🇸
Genomic Research ExpansionThe U.S. short-read sequencing market benefits from sustained investment in clinical genomics, biomedical research, and precision medicine initiatives. Laboratories increasingly adopt high-throughput sequencing platforms that improve scalability, analytical accuracy, and workflow efficiency.
Segment Leadership and Growth Trends
Short-read Sequencing Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Consumables (Largest Segment) vs Services (Fastest-Growing Segment)
In the short-read sequencing market, consumables represented the largest product segment with a 60.77% share in 2026, reflecting their essential role throughout sequencing workflows. Reagents, kits, flow cells, and other consumable materials are repeatedly required to prepare, process, and sequence biological samples, creating recurring demand alongside sequencing activity. Expanding genomic research, molecular diagnostics, and life science applications continues to support the sustained use of sequencing consumables across laboratories and research environments.
Services are emerging as the fastest-growing product segment as sequencing users increasingly seek specialized expertise for experimental design, sample processing, platform operation, and interpretation of sequencing outputs. Outsourced services can help organizations access advanced sequencing capabilities without requiring extensive in-house infrastructure or specialized personnel. Growing adoption of sequencing across research, clinical, and pharmaceutical applications is therefore creating opportunities for service providers that can deliver efficient and technically sophisticated sequencing support.
Workflow Segment Analysis: Sequencing (Largest Segment) vs Data Analysis (Fastest-Growing Segment)
The sequencing segment held the largest share of the short-read sequencing market at 59.47% in 2026, reflecting its central position in generating high-quality genetic information. Sequencing remains the core analytical stage through which prepared samples are converted into genomic data, supporting applications ranging from research and biomarker discovery to clinical and pharmaceutical studies. Continued use of short-read technologies for accurate and scalable genomic analysis maintains strong demand for sequencing workflows.
Data analysis is advancing as the fastest-growing workflow segment as the volume and complexity of sequencing outputs increase. Advanced computational approaches are increasingly important for transforming raw sequencing information into meaningful biological insights, including variant identification, genomic characterization, and comparative analysis. The growing integration of bioinformatics and computational interpretation into sequencing workflows is strengthening demand for specialized data-analysis capabilities and supporting more efficient use of generated genomic data.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Instruments, Consumables, Services | Consumables | Services |
| Workflow | Pre-Sequencing, Sequencing, Data Analysis | Sequencing | Data Analysis |
| Application | Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing & Resequencing, Others | Targeted Sequencing & Resequencing | Whole Genome Sequencing |
| End-Use | Academic & Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others | Academic & Research Institutes | Pharmaceutical & Biotechnology Companies |
Competitive Landscape and Market Positioning
Major players in the short-read sequencing market:
1. Illumina Inc. (United States)
2. Thermo Fisher Scientific Inc. (United States)
3. BGI Genomics Co. Ltd. (China)
4. QIAGEN N.V. (Netherlands)
5. Agilent Technologies Inc. (United States)
6. Revvity Inc. (United States)
7. Azenta Inc. (United States)
8. Psomagen Inc. (United States)
9. F. Hoffmann-La Roche Ltd. (Switzerland)
The short-read sequencing market is expanding with strong momentum in genomic research and clinical diagnostics applications. Improvements in sequencing speed, accuracy, and computational analysis are driving broader adoption across research ecosystems. Continuous technological upgrades and integrated bioinformatics solutions are enabling more efficient genomic interpretation, while collaborative research initiatives are accelerating innovation cycles.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Illumina Inc. (United States) | |||||||
| Thermo Fisher Scientific Inc. (United States) | |||||||
| BGI Genomics Co. Ltd. (China) | |||||||
| QIAGEN N.V. (Netherlands) | |||||||
| Agilent Technologies Inc. (United States) | |||||||
| Revvity Inc. (United States) | |||||||
| Azenta Inc. (United States) | |||||||
| Psomagen Inc. (United States) | |||||||
| F. Hoffmann-La Roche Ltd. (Switzerland). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| PacBio | May-26 | PacBio reported its Q1 2026 financial results for the quarter ended March 31, 2026, providing insights into revenue performance and commercial traction of its sequencing platforms. The update reflects broader adoption trends and competitive positioning within the genomics sequencing market, offering visibility into operational momentum and market demand dynamics. |
| Element Biosciences | Feb-26 | Element Biosciences introduced the VITARI sequencing system, a high-throughput benchtop platform designed to approach the $100 whole-genome sequencing threshold. The system significantly reduces sequencing costs while improving scalability and accessibility, intensifying competitive pressure in the short-read sequencing market through lower-cost genomic throughput and expanded adoption potential. |
| Illumina | Sep-25 | Illumina launched Illumina Protein Prep, an assay enabling next-generation sequencing-based proteomics research. The solution integrates proteomics with large-scale genomics studies across oncology, cardiometabolic, and immunologic applications, expanding Illumina’s platform utility and strengthening its position in multi-omics workflows within the sequencing ecosystem. |
| QIAGEN | Jul-25 | QIAGEN introduced QIAseq xHYB Long Read Panels, a targeted enrichment solution designed to support long-read sequencing of complex genomic regions. The panels are optimized for compatibility with native long-read platforms such as PacBio, improving detection of diverse genomic variants and enhancing QIAGEN’s role in enabling advanced sequencing workflows. |
| Roche | Feb-25 | Roche launched its sequencing by expansion (SBX) technology, a proprietary next-generation sequencing method paired with a sensor module. The system is designed to enable rapid and scalable sequencing across applications, strengthening Roche’s competitive positioning in sequencing technology through a differentiated chemistry approach. |
| Illumina | Dec-23 | Firalis Molecular Precision expanded its genomics capabilities by acquiring Illumina’s NovaSeq X Plus Sequencing System. The platform enables dual flow cell sequencing, improving throughput and scalability of short-read sequencing operations and supporting increased capacity for large-scale genomic research and commercial applications. |
| PacBio | Aug-23 | PacBio began commercializing the Onso short-read sequencing system in the United States, leveraging sequencing-by-binding (SBB) chemistry. The platform is designed to deliver high accuracy in a benchtop format, supporting broader adoption of short-read sequencing and enhancing PacBio’s competitive presence in the next-generation sequencing market. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Short-read Sequencing Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Sequencing Technology | Sequencing-by-Synthesis, Sequencing-by-Ligation, Semiconductor Sequencing, Other Short-read Technologies |
| Sample Type | Blood & Plasma, Tissue & FFPE Samples, Saliva & Buccal Samples, Microbial Samples, Cell & Other Biological Samples |
| Deployment Model | Centralized Sequencing Facilities, Decentralized Laboratory Sequencing, Core Facility & Shared Infrastructure Models |
Short-read Sequencing Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Precision Medicine Integration Strategy |
|
| Data Infrastructure and Bioinformatics Ecosystem |
|
| Clinical Sequencing Reimbursement Landscape |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the short-read sequencing market?
How much is the short-read sequencing industry expected to grow by 2036?
How is the shift toward outsourced sequencing services changing operational models in genomics workflows?
What is driving the increasing strategic importance of data analysis within short-read sequencing workflows?
Why do consumables account for the largest share of the short-read sequencing market?
Which workflow segment is growing fastest in the short-read sequencing market?
Why does North America lead the short-read sequencing market?
What is driving rapid growth in the Asia Pacific short-read sequencing market?
Which companies are driving growth in the short-read sequencing landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization